基本信息
views: 5
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Bear is particularly known for his pioneering efforts in breast cancer, and other breast disease, care and research. He has served on the Board of Directors of the National Surgical Adjuvant Breast and Bowel Project (NSABP) group for more than 20 years, and has been Study Chair for two of this group’s international breast cancer trials. In 2009 he received the NSABP Foundation Distinguished Investigator Lifetime Achievement Award. He has advanced the care of women with breast cancer through the use of neoadjuvant chemotherapy allowing for more opportunities for breast conservation.
Dr. Bear has a long record of NIH/NCI funding , and is the local principal investigator for most of MCC’s current breast cancer clinical trials. He is also co-principal investigator on a Minority-Underserved NCI Community Oncology research program grant which will provide $4.4 million in funding over fi ve years to support clinical trials at VCU and community partner sites. Dr. Bear was awarded a US patent (US8741642 B2) in 2014 for Methods for Producing Autologous Immune Cells Resistant to Myeloid-Derived Suppressor Cells Effects. With over 160 peer reviewed articles and over 100 abstracts, his work has been published in the New England Journal of Medicine, Journal of Surgial Oncology, Journal of Clinical Oncology, and other prestigious journals.
Dr. Bear has a long record of NIH/NCI funding , and is the local principal investigator for most of MCC’s current breast cancer clinical trials. He is also co-principal investigator on a Minority-Underserved NCI Community Oncology research program grant which will provide $4.4 million in funding over fi ve years to support clinical trials at VCU and community partner sites. Dr. Bear was awarded a US patent (US8741642 B2) in 2014 for Methods for Producing Autologous Immune Cells Resistant to Myeloid-Derived Suppressor Cells Effects. With over 160 peer reviewed articles and over 100 abstracts, his work has been published in the New England Journal of Medicine, Journal of Surgial Oncology, Journal of Clinical Oncology, and other prestigious journals.
Research Interests
Papers共 327 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 6_Supplement (2024): 7553-7553
Cancer Researchno. 9_Supplement (2024): PO4-02
Harry Bear,Xiaoyan Deng,Dipankar Bandyopadhyay,Michael Idowu,Maciej Kmieciak, Monique Williams, Giovanni Archer, Lindsey Gwaltney,Patrick Dillon, Daniel Flora, Daniel Stover,Andrew Poklepovic,
Cancer Researchno. 9_Supplement (2024): PO1-18
Cancer Researchno. 6_Supplement (2024): 7664-7664
European Journal of Cancer (2024): 113420-113420
Matthew Emilio Fernandez, Yasir Alshehry,Laura Graham,Jennifer E. Koblinski,Harry D. Bear, Doug H. Sweet,Sandro R. da Rocha
Cancer Researchno. 6_Supplement (2024): 6521-6521
F. Marmé,M. Martin, M. Untch, C. Thode,H. Bonnefoi,S.-B. Kim,H. Bear, N. Mc Carthy, K. Gelmon,J.A. García-Sáenz, C.M. Kelly, T. Reimer,
ESMO Openno. 6 (2024): 103466-103466
EUROPEAN JOURNAL OF CANCER (2024)
Brian K. Sparkman, Tina Wong, Westin Stover, Catalina Mosquera, Andrew Francis,Dipankar Bandyopadhyay, Jian He, Atika Farzana Urmi,Harry Bear,Raphael Louie,Kandace McGuire
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S108-S108
Cited0Views0Bibtex
0
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn